Tellgen Corp - Asset Resilience Ratio

Latest as of September 2025: 8.60%

Tellgen Corp (300642) has an Asset Resilience Ratio of 8.60% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Tellgen Corp (300642) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥171.97 Million
≈ $25.16 Million USD Cash + Short-term Investments

Total Assets

CN¥2.00 Billion
≈ $292.77 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Tellgen Corp's Asset Resilience Ratio has changed over time. See 300642 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tellgen Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300642 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥171.97 Million 8.6%
Total Liquid Assets CN¥171.97 Million 8.60%

Asset Resilience Insights

  • Limited Liquidity: Tellgen Corp maintains only 8.60% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Tellgen Corp Industry Peers by Asset Resilience Ratio

Compare Tellgen Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Beijing Wandong Medical Technology Co Ltd
SHG:600055
Medical Devices 4.92%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
MODULIGHT OY EO 1
F:78W
Medical Devices 22.31%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.39%
Theradiag SA
PA:ALTHE
Medical Devices 15.59%
Nova EYE Medical Ltd
AU:EYE
Medical Devices 11.08%

Annual Asset Resilience Ratio for Tellgen Corp (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Tellgen Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 10.39% CN¥181.75 Million
≈ $26.60 Million
CN¥1.75 Billion
≈ $255.93 Million
+4.26pp
2023-12-31 6.13% CN¥103.02 Million
≈ $15.07 Million
CN¥1.68 Billion
≈ $245.80 Million
-9.54pp
2022-12-31 15.67% CN¥260.88 Million
≈ $38.17 Million
CN¥1.66 Billion
≈ $243.60 Million
-2.43pp
2021-12-31 18.10% CN¥271.35 Million
≈ $39.71 Million
CN¥1.50 Billion
≈ $219.33 Million
+0.33pp
2020-12-31 17.77% CN¥243.77 Million
≈ $35.67 Million
CN¥1.37 Billion
≈ $200.73 Million
-5.62pp
2019-12-31 23.39% CN¥291.60 Million
≈ $42.67 Million
CN¥1.25 Billion
≈ $182.40 Million
+23.89pp
2018-12-31 -0.50% CN¥-5.47 Million
≈ $-800.28K
CN¥1.10 Billion
≈ $161.38 Million
+0.18pp
2017-12-31 -0.68% CN¥-6.37 Million
≈ $-931.69K
CN¥935.16 Million
≈ $136.84 Million
--
pp = percentage points

About Tellgen Corp

SHE:300642 China Medical Devices
Market Cap
$392.70 Million
CN¥2.68 Billion CNY
Market Cap Rank
#13772 Global
#4340 in China
Share Price
CN¥16.51
Change (1 day)
+0.30%
52-Week Range
CN¥13.71 - CN¥31.30
All Time High
CN¥46.24
About

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more